MedTrace Logo

Influence of Plasma Rich in Growth Factors (PRGF) on Healing of Medial Collateral Ligament (MCL) Tear

NCT00743886 · Status: WITHDRAWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2011-07-12

No results posted yet for this study

Summary

To evaluate the influence of Plasma Rich in Growth Factors (PRGF) on the healing process of medial collateral ligament (MCL) tear.

Conditions

  • MCL Tear

Interventions

BIOLOGICAL

Plasma Rich in Growth Factors (PRGF)

injection onto injured area in ligament dose: 3-6mg

DRUG

saline

injection of 6 cc of saline into injured area

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Principal Investigators

  • Omer Mei Dan, Dr · Meir Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-02-28
Completion
2009-03-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00743886 on ClinicalTrials.gov